SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-060917
Filing Date
2007-08-09
Accepted
2007-08-09 16:17:36
Documents
6
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-18806_110q.htm 10-Q 517059
2 EX-10.60 a07-18806_1ex10d60.htm EX-10.60 159311
3 EX-10.61 a07-18806_1ex10d61.htm EX-10.61 169532
4 EX-31.1 a07-18806_1ex31d1.htm EX-31.1 11232
5 EX-31.2 a07-18806_1ex31d2.htm EX-31.2 11395
6 EX-32 a07-18806_1ex32.htm EX-32 8967
  Complete submission text file 0001104659-07-060917.txt   879004
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 071040642
SIC: 2834 Pharmaceutical Preparations